STEPHANIE QUINN: Open Payments
NPI 1992886642 · ROANOKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$580 in 29 payments from 7 companies in 2025. Trend: 2023 $540 · 2024 $258 · 2025 $580
Food & beverage: $580
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 10 | $197 |
| Organon LLC | 5 | $117 |
| Exeltis, USA Inc. | 3 | $76 |
| Astellas Pharma US Inc | 4 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $71 |
| Amgen Inc. | 2 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
Products named: ZURZUVAE, NEXPLANON, SLYND, Veozah, Mirena, Lynkuet, EVENITY, MYFEMBREE.
Industry payments across VA — which companies pay providers there.
